Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Microbot Medical ( (MBOT) ) has issued an update.
On June 30, 2025, Microbot Medical Inc. announced its inclusion in the Russell Microcap® Index, effective immediately. This milestone reflects the company’s strong execution and momentum, particularly as it prepares for the anticipated Q3 launch of its LIBERTY Endovascular Robotic System, pending FDA clearance. The inclusion enhances Microbot Medical’s visibility at a crucial time, potentially impacting its operational and commercial strategies positively.
The most recent analyst rating on (MBOT) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. is a pre-commercial stage medical technology company focused on redefining endovascular robotics. It has developed the world’s first single-use, fully disposable endovascular robotic system, aiming to improve the quality of care for patients and providers globally.
Average Trading Volume: 2,606,517
Technical Sentiment Signal: Buy
Current Market Cap: $90.94M
Learn more about MBOT stock on TipRanks’ Stock Analysis page.